Describe Fluorescyl-tyramide Amplification.

• A. Peroxidase is associated with a tissue-bound primary antibody via a secondary anti-mouse antibody to which peroxidase is conjugated; peroxidase catalyzes deposition of fluorescein-tyramide onto the tissue; increases sensitivity by about 50-fold.
• B. Direct labeling of primary antibodies with fluorophores.
• C. Use of DAB precipitation.
• D. Western blot.

Answer: (A)

Fluorescyl-tyramide amplification uses an enzymatic amplification strategy to boost the fluorescent signal at the site of the antigen. In this approach, a tissue-bound primary antibody is recognized by a secondary antibody that carries horseradish peroxidase (HRP). When a fluorescein-tyramide substrate is introduced, the HRP catalyzes the oxidation of the tyramine moiety, generating a reactive tyramine intermediate that covalently binds to nearby tyrosine residues on surrounding proteins. The result is the deposition of fluorescein precisely at the antigen location, producing a much brighter and more localized fluorescent signal. This amplification can be substantial, often around 50-fold, enabling detection of low-abundance targets and improving signal-to-noise for immunofluorescence experiments.

In contrast, directly labeling primary antibodies with fluorophores provides no amplification and relies on the inherent signal of a single binding event. DAB precipitation yields a chromogenic, not fluorescent, signal and is used for colorimetric IHC rather than fluorescence. Western blotting is a separate technique used for detecting proteins in a gel, not for visualizing antigen localization in tissue sections.